Medicare Enrolled
Dr. Christopher Riemann, M.D.
Ophthalmology · Cincinnati, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Riemann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Riemann?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Riemann
Dr. Christopher Riemann is an ophthalmology specialist in Cincinnati, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Riemann performed 20,022 Medicare services across 2,573 unique beneficiaries.
Between the years covered by Open Payments, Dr. Riemann received a total of $522,097 from 41 pharmaceutical and/or device companies across 466 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Riemann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in OH
$522,097 industry payments
Medicare Practice Summary
Medicare Utilization ↗20,022
Medicare services
Top 4% in OH for ophthalmology
2,573
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,001 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
13,200 | $29 | $40 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
1,547 | $28 | $158 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
1,117 | $90 | $489 |
| Aflibercept eye injection (Eylea) | 1,110 | $684 | $3,780 |
| Injection, brolucizumab-dbll, 1 mg | 738 | $247 | $1,270 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
564 | $17 | $99 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
435 | $264 | $541 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
383 | $87 | $506 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
251 | $80 | $487 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
186 | $61 | $356 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
153 | $94 | $442 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
105 | $1 | $6 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
33 | $33 | $201 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
26 | $221 | $1,273 |
| Injection into eye membrane A procedure involving the injection of a drug or substance into the membrane that covers the eyeball. |
26 | $34 | $259 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
24 | $1,768 | $2,349 |
| Complex detached retina repair with eye fluid drainage A surgical procedure to repair a detached retina and drain fluid located between the lens and the retina. |
23 | $952 | $4,896 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
22 | $565 | $3,465 |
| Retinal membrane and internal limiting membrane removal A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina. |
22 | $867 | $4,502 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $128 | $658 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
15 | $35 | $239 |
| Retinal detachment repair with fluid drainage A surgical procedure to reattach a detached retina by draining excess fluid from the space between the lens and the retina. |
13 | $890 | $4,581 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
12 | $26 | $151 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$522,097
Total received (2018-2024)
Avg $74,585/year across 7 years
Top 1% in OH for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
466
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$400,957 (76.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$73,409 (14.1%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$27,201 (5.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,530 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$51,669
2023
$47,343
2022
$31,398
2021
$58,993
2020
$79,995
2019
$119,641
2018
$133,057
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
MedOne Surgical Inc
$16,733
Astellas Pharma US Inc
$13,996
Dutch Ophthalmic Research Center (International) B.V.
$9,536
Dutch Ophthalmic, USA
$4,081
Haag-Streit USA, Inc.
$2,633
Alimera Sciences, Inc.
$2,373
Regeneron Healthcare Solutions, Inc.
$550
Bausch & Lomb Americas Inc.
$273
ABBVIE INC.
$254
ANI Pharmaceuticals, Inc.
$209
Genentech USA, Inc.
$177
Astellas US LLC
$136
Apellis Pharmaceuticals, Inc.
$129
Mallinckrodt Hospital Products Inc.
$120
Alcon Vision LLC
$102
Sandoz Inc.
$98
Biogen, Inc.
$75
Regeneron Pharmaceuticals, Inc.
$74
Spark Therapeutics, Inc.
$65
Astellas Pharma Global Development
$33
Amgen Inc.
$22
Top 3 companies account for 77.9% of 2024 payments
All-time payments by company (2018-2024) ›
Reliance Medical Products, Inc.
$145,323
MedOne Surgical Inc
$82,160
RELIANCE MEDICAL PRODUCTS, INC.
$55,047
Astellas Pharma US Inc
$36,830
Dutch Ophthalmic Research Center (International) B.V.
$36,548
Alcon Research Ltd
$27,201
Alcon Vision LLC
$23,209
Haag-Streit USA, Inc.
$22,339
Alcon Research LLC
$16,019
Novartis Pharmaceuticals Corporation
$12,907
Alcon Laboratories Inc
$11,048
NotalVision
$8,625
Alimera Sciences, Inc.
$7,151
Bausch & Lomb, a division of Bausch Health US, LLC
$6,856
Bausch & Lomb Americas Inc.
$6,042
Allergan Inc.
$5,246
Dutch Ophthalmic, USA
$4,168
Genentech, Inc.
$2,819
Regeneron Healthcare Solutions, Inc.
$2,513
Carl Zeiss Meditec, Inc.
$2,315
Allergan, Inc.
$1,960
Janssen Research & Development, LLC
$938
Genentech USA, Inc.
$799
ABBVIE INC.
$739
EyePoint Pharmaceuticals US, Inc.
$624
Apellis Pharmaceuticals, Inc.
$615
W. L. Gore & Associates, Inc.
$580
Spark Therapeutics, Inc.
$336
ANI Pharmaceuticals, Inc.
$209
Astellas US LLC
$136
Carl Zeiss Meditec USA, Inc.
$135
Biogen, Inc.
$123
Mallinckrodt Hospital Products Inc.
$120
Regeneron Pharmaceuticals, Inc.
$117
Sandoz Inc.
$98
Marco Ophthalmic, Inc.
$56
Aerie Pharmaceuticals, Inc.
$53
Astellas Pharma Global Development
$33
Janssen Global Services, LLC
$29
Amgen Inc.
$22
Ellex, Inc
$11
Top 3 companies account for 54.1% of all-time payments
Associated products mentioned in payments ›
2RT Retinal Rejuvination Therapy Laser System · ACTHAR · ARTEVO 800 · AcrySof · BEOVU · BYOOVIZ · Centurion · Cimerli · Clareon · Constellation · DEXYCU · EVA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ForeseeHome · ILUVIEN · Iluvien · Izervay · LOTEMAX · LOTEMAX SM · LUXTURNA · Lucentis · Luxor · NGENUITY · OPD-III · OZURDEX · PIPELINE · PROLENSA · PURIFIED CORTROPHIN GEL · Product in Development · RETISERT · Rhopressa · SIMBRINZA · SUSVIMO · Susvimo · Syfovre · TEPEZZA · VABYSMO · VISUDYNE · VUITY · Vabysmo · XIIDRA · XIPERE · YUTIQ · combined machine · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (77%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for ophthalmology in OH.
Geographic Context
Ophthalmologists within 10 mi
151
Per 100K population
18.2
County median income
$70,816
Nearest hospital
BETHESDA NORTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Riemann is a mixed practice specialist, with above-average Medicare volume (top 4% in OH), with consulting-driven industry engagement in the top 1% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Riemann experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Riemann performed 13,200 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Riemann receive payments from pharmaceutical companies?
Yes. Dr. Riemann received a total of $522,097 from 41 companies across 466 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Riemann's costs compare to other ophthalmologists in Cincinnati?
Dr. Riemann's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Riemann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Cincinnati
Browse ophthalmologists in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in OH
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in OH
Which OH ophthalmologists receive the most from drug and device companies.
By company
Reliance Medical Products, Inc. Payments to Doctors
See all physicians who received payments from Reliance Medical Products, Inc.
By company
MedOne Surgical Inc Payments to Doctors
See all physicians who received payments from MedOne Surgical Inc.
By company
RELIANCE MEDICAL PRODUCTS, INC. Payments to Doctors
See all physicians who received payments from RELIANCE MEDICAL PRODUCTS, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology